Introduction
Left ventricular hypertrophy (LVH) is an important prognosticator for cardiovascular (CV) risk in persons with and without arterial hypertension. Given the high prevalence of these conditions, LVH screening is mandatory for CV prevention. Although not evaluated in a middle aged preventive medicine population, Electrocardiography (ECG) is widely used for LVH screening. Although not widely accessible as a screening technique, cardiovascular magnetic resonance (CMR) offers a unique opportunity to calculate LV mass index (LVMI) as the gold standard for other diagnostic tests.
Purpose
To assess the reliability of ECG LVH criteria compared to CMR ventriculometry (cutoff: LVMI 83 g/m 2 ) and the incremental value of CMR in a population from a prevention programme.
Methods 220 (206 male, age 49.5 ± 8,4 years) consecutive participants of a prevention programme without known heart disease underwent CMR in a 1.5 T scanner (Magnetom Avanto, Siemens, Erlangen, Germany) including SSFP Cine (TrueFISP TR 3ms, TE 1.5 ms, FA 72°, slice thickness 6 mm) and delayed enhancement imaging.
LVMI was derived from contiguous short axis cine images using the summation of discs method. These data were compared to Sokolow-Lyon amplitude, Sokolow-Lyon duration product, Cornell amplitude, Cornell duration product, and Romhild-Estes score (Tables 1,2) in 12 lead ECG.
Results
31 participants had positive LVH criteria in ECG, of which 6, and 4 ECG negatives, showed LVH (LVMI > 83 g/m 2 ) in CMR ( Figure 2 ). All ECG criteria were positively correlated with LV mass (Table 3) . Specificities and negative predictive values were high in our low- 
